A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Recruiting · NCT07769502 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers | neoplasm, pancreatic ductal adenocarcinoma | Recruiting | Phase 2 | 2026-09-22 | NCT07769502 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Medical University Hospital /ID# 281981 | Taichung | Taiwan | 1 |
| Hadassah Medical Center-Hebrew University /ID# 281620 | Jerusalem | Israel | 1 |
| Kanagawa Cancer Center /ID# 281899 | Yokohama | Japan | 1 |
| National Cancer Center Hospital /ID# 281870 | Chuo-Ku | Japan | 1 |
| Osaka International Cancer Institute /ID# 281900 | Osaka | Japan | 1 |
| The Chaim Sheba Medical Center /ID# 281618 | Ramat Gan | Israel | 1 |